Chu Brest
Brest, 29200, France
NCT Number: NCT07000474
The primary goal of this observational study is to assess the predictive value of a model developed through a multiparametric analysis of clinical images, histopathological data, CT scans, and molecular analysis. This analysis will be conducted on a retrospective cohort recruited at CHU Brest (training group). The model will then be validated using external cohorts from other centers (test group).
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Observational
Brest, 29200, France
Around 20% of patients with colorectal cancer present with synchronous liver metastases at the time of diagnosis. In recent years, there has been increasing interest in the high-throughput extraction of quantitative data from medical images, a technique known as radiomics. Radiomic analysis can involve both qualitative and quantitative imaging parameters, which may be used independently or integrated into multiparametric prediction models.
This is a multicenter, retrospective study designed to investigate the demographic, clinical, and radiological features, treatment regimens, and outcomes of patients diagnosed with colorectal cancer. The study will involve the collection of anonymized clinical data, including age, sex, diagnosis date, treatment details, results from histopathological and genetic analyses, as well as pre- and post-treatment medical imaging typically performed as part of the management of colorectal cancer patients, along with survival and tumor recurrence data.
PRIMARY EVALUATION CRITERIA Prediction of recurrence/treatment response based on the radiomic model.
SECONDARY EVALUATION CRITERIA The impact of CT scan image acquisition and reconstruction parameters on the prognostic model.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients who have undergone surgery for colorectal cancer.
Exclusion criteria
Multiparametric analysis of clinical images, histopathological images, CT scans, and molecular analysis.
Time frame: 2 years
The primary objective is to evaluate the predictive value of a model built through multiparametric analysis of clinical images, histopathological images, CT scans, and molecular analysis.
University Hospital, Brest
Other
Multiparametric Characterization of Colorectal Cancers
Acronym: METRAD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04084249
Colo-rectal Cancer, Colonic Cancer
Herlev, Capital Region of Denmark, Denmark
View Trial DetailsNCT03565029
Colo-rectal Cancer, Colonic Diseases
Milan, Italy
View Trial DetailsNCT06709170
Colo-rectal Cancer, Colonic Diseases
Seoul, Jongro-gu, South Korea
View Trial DetailsNCT04103372
Colo-rectal Cancer, Colonic Diseases
Reading, Berkshire, United Kingdom
View Trial Details